FindTrial
Sign In

Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00951145
Enrollment
Unknown
Registered
2009-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2013-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Hip

Brief summary

This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.

Interventions

None listed

Sponsors

Stryker Orthopaedics
CollaboratorINDUSTRY
Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem. 2. Patients with hip fracture undergoing THA will also be included. 3. Patients willing and able to comply with follow-up requirements and self-evaluations.

Design outcomes

Primary

MeasureTime frame
The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem—

Secondary

MeasureTime frame
Proximally coated tapered stems can be used for patients with various bone types, bone morphology, and underlying diagnosis—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026